Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Intelligent Bio Solutions Inc. (INBS) had Revenue of $0.71M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$0.71M
Net Income	$-3.09M
Cost of Goods Sold	$0.51M
Gross Profit	$0.20M
Operating Expenses	$3.81M
Operating Income	$-3.10M
Non-Operating Income/Expense	$-0.00M
Pre-Tax Income	$-3.10M
Normalized Pre-Tax Income	$-3.10M
Income after Taxes	$-3.10M
Income from Continuous Operations	$-3.10M
Consolidated Net Income/Loss	$-3.10M
Normalized Income after Taxes	$-3.10M
EBIT	$-3.10M
EBITDA	$-2.86M
Weighted-Average Shares Outstanding (Basic)	5.27M
Weighted-Average Shares Outstanding (Diluted)	5.27M
Earnings per Share (EPS) (Basic)	$-0.36
Earnings per Share (EPS) (Diluted)	$-0.36
Balance Sheet Financials
Current Assets	$4.14M
Property, Plant, and Equipment	$0.25M
Long-Term Assets	$4.11M
Total Assets	$8.25M
Current Liabilities	$5.35M
Long-Term Debt	--
Long-Term Liabilities	$0.08M
Total Liabilities	$5.44M
Common Equity	$2.81M
Tangible Shareholders Equity	$-0.98M
Shareholders Equity	$2.81M
Common Shares Outstanding	7.32M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-9.68M
Cash Flow from Investing Activities	$-0.23M
Cash Flow from Financial Activities	$4.60M
Beginning Cash	$6.30M
End Cash	$1.02M
Increase/Decrease in Cash	$-5.28M
Stock-Based Compensation	$0.24M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.77
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	0.07
Gross Margin	28.43%
Operating Margin	-436.70%
EBIT Margin	-436.70%
EBITDA Margin	--
Pre-Tax Profit Margin	-436.84%
Profit Margin	-435.08%
Free Cash Flow	$-9.91M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.80
Receiveable Turnover	0.53
Days Sales in Receivables	168.41
Return on Equity	-110.26%
Return on Tangible Equity	317.73%
Return on Assets	-37.61%
Return on Investments	-110.26%
Book Value Per Share	$0.38
Free Cash Flow per Share	$-1.88
Operating Cash Flow per Share	$-1.83

Data from Zacks Investment Research, Inc.